Retinal proteome alterations in a mouse model of type 2 diabetes

Aims/hypothesisDiabetic retinopathy is a major complication of type 2 diabetes and the leading cause of blindness in adults of working age. Neuronal defects are known to occur early in disease, but the source of this dysfunction is unknown. The aim of this study was to examine differences in the retinal membrane proteome among non-diabetic mice and mouse models of diabetes either with or without metformin treatment.MethodsAlterations in the retinal membrane proteome of 10-week-old diabetic db/db mice, diabetic db/db mice orally treated with the anti-hyperglycaemic metformin, and congenic wild-type littermates were examined using label-free mass spectrometry. Pathway enrichment analysis was completed with Genomatix and Ingenuity. Alterations in Slc17a7 mRNA and vesicular glutamate transporter 1 (VGLUT1) protein expression were evaluated using real-time quantitative PCR and immunofluorescence.ResultsA total of 98 proteins were significantly differentially abundant between db/db and wild-type animals. Pathway enrichment analysis indicated decreases in levels of proteins related to synaptic transmission and cell signalling. Metformin treatment produced 63 differentially abundant proteins compared with untreated db/db mice, of which only 43 proteins were found to occur in both datasets, suggesting that treatment only partially normalises the alterations induced by diabetes. VGLUT1, which is responsible for loading glutamate into synaptic vesicles, was found to be differentially abundant in db/db mice and was not normalised by metformin. The decrease in Slc17a7/VGLUT1 was confirmed by transcriptomic and immunocytochemical analysis.Conclusions/interpretationThese findings expand the knowledge of the protein changes in diabetic retinopathy and suggest that membrane-associated signalling proteins are susceptible to changes that are partially ameliorated by treatment.

[1]  V. Porciatti,et al.  Nonselective Loss of Contrast Sensitivity in Visual System Testing in Early Type I Diabetes , 1992, Diabetes Care.

[2]  R. Holman,et al.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.

[3]  P. Whelton,et al.  End-Stage Renal Disease Attributable to Diabetes Mellitus , 1994, Annals of Internal Medicine.

[4]  T. Kraft,et al.  Oscillatory potential analysis and ERGs of normal and diabetic rats. , 2004, Investigative ophthalmology & visual science.

[5]  K. Trudeau,et al.  Reduced connexin 43 expression and its effect on the development of vascular lesions in retinas of diabetic mice. , 2010, Investigative ophthalmology & visual science.

[6]  Werner Müller,et al.  Introducing the German Mouse Clinic: open access platform for standardized phenotyping , 2005, Nature Methods.

[7]  U. Lindblad,et al.  Electrophysiological studies in newly onset type 2 diabetes without visible vascular retinopathy , 2011, Documenta Ophthalmologica.

[8]  M. Schneck,et al.  Retinal function in normal and diabetic eyes mapped with the slow flash multifocal electroretinogram. , 2004, Investigative ophthalmology & visual science.

[9]  I. Yamaguchi,et al.  Development of hyperglycaemia and insulin resistance in conscious genetically diabetic (C57BL/KsJ-db/db) mice , 1994, Diabetologia.

[10]  R. Simó,et al.  Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy , 2007, Diabetologia.

[11]  M. Owen,et al.  Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. , 2000, The Biochemical journal.

[12]  A. Vingrys,et al.  Paired-flash identification of rod and cone dysfunction in the diabetic rat. , 2004, Investigative ophthalmology & visual science.

[13]  J. Neaton,et al.  Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.

[14]  W. Green,et al.  A potential role for β‐ and γ‐crystallins in the vascular remodeling of the eye , 2005 .

[15]  T. Sano,et al.  [Diabetic retinopathy]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.

[16]  C. Gerhardinger,et al.  Müller cell changes in human diabetic retinopathy. , 1998, Diabetes.

[17]  Jin-Dao Wu,et al.  Comparative Proteome Analysis of Neural Retinas from Type 2 Diabetic Rats by Two-dimensional Electrophoresis , 2007, Current eye research.

[18]  R. Hernández-Muñoz,et al.  Changes in the Redox State in the Retina and Brain During the Onset of Diabetes in Rats , 1998, Neurochemical Research.

[19]  M. Ueffing,et al.  Isotope Coded Protein Labeling Coupled Immunoprecipitation (ICPL-IP): A Novel Approach for Quantitative Protein Complex Analysis From Native Tissue* , 2012, Molecular & Cellular Proteomics.

[20]  H. Xiang,et al.  Human αA- and αB-crystallins bind to Bax and Bcl-XS to sequester their translocation during staurosporine-induced apoptosis , 2004, Cell Death and Differentiation.

[21]  S. Larsen,et al.  Metformin-treated patients with type 2 diabetes have normal mitochondrial complex I respiration , 2012, Diabetologia.

[22]  D. Foster,et al.  Detection of colour vision abnormalities in uncomplicated type 1 diabetic patients with angiographically normal retinas. , 1992, The British journal of ophthalmology.

[23]  H. D. Vanguilder,et al.  Multi-Modal Proteomic Analysis of Retinal Protein Expression Alterations in a Rat Model of Diabetic Retinopathy , 2011, PloS one.

[24]  A. Vingrys,et al.  A role for omega-3 polyunsaturated fatty acid supplements in diabetic neuropathy. , 2010, Investigative ophthalmology & visual science.

[25]  A. Feuchtinger,et al.  Deciphering Membrane-Associated Molecular Processes in Target Tissue of Autoimmune Uveitis by Label-Free Quantitative Mass Spectrometry* , 2010, Molecular & Cellular Proteomics.

[26]  H. Parving,et al.  Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial , 2008, The Lancet.

[27]  R. DeFronzo,et al.  Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus. , 1996, The Journal of clinical endocrinology and metabolism.

[28]  A. Schmidt,et al.  The RAGE axis in early diabetic retinopathy. , 2005, Investigative ophthalmology & visual science.

[29]  H. Xiang,et al.  Human alphaA- and alphaB-crystallins bind to Bax and Bcl-X(S) to sequester their translocation during staurosporine-induced apoptosis. , 2004, Cell death and differentiation.

[30]  L. Aiello,et al.  Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy. , 2008, Journal of proteome research.

[31]  A. Vingrys,et al.  Rod photoreceptor dysfunction in diabetes: activation, deactivation, and dark adaptation. , 2006, Investigative ophthalmology & visual science.

[32]  R W Rodieck,et al.  Components of the electroretinogram--a reappraisal. , 1972, Vision research.

[33]  B. Gabryel,et al.  Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide , 2010, Pharmacological reports : PR.

[34]  S. Chung,et al.  Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice. , 2005, Diabetes.

[35]  H. Fuchs,et al.  Innovations in phenotyping of mouse models in the German Mouse Clinic , 2012, Mammalian Genome.

[36]  R. Simó,et al.  Elevation of apolipoprotein A-I and apolipoprotein H levels in the vitreous fluid and overexpression in the retina of diabetic patients. , 2008, Archives of ophthalmology.

[37]  D TOUSSAINT,et al.  Retinal vascular patterns. IV. Diabetic retinopathy. , 1961, Archives of ophthalmology.

[38]  M. Pu,et al.  Physiological Effects of Superoxide Dismutase on Altered Visual Function of Retinal Ganglion Cells in db/db Mice , 2012, PloS one.

[39]  E. Fletcher,et al.  Early inner retinal astrocyte dysfunction during diabetes and development of hypoxia, retinal stress, and neuronal functional loss. , 2011, Investigative ophthalmology & visual science.

[40]  T. Gardner,et al.  Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group. , 2000, Investigative ophthalmology & visual science.

[41]  C. Nordgaard,et al.  Human retinal pigment epithelium proteome changes in early diabetes , 2008, Diabetologia.

[42]  W. Green,et al.  A potential role for beta- and gamma-crystallins in the vascular remodeling of the eye. , 2005, Developmental dynamics : an official publication of the American Association of Anatomists.

[43]  H. King,et al.  Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections , 1998, Diabetes Care.

[44]  A. Clermont,et al.  Angiotensin AT1 receptor antagonism ameliorates murine retinal proteome changes induced by diabetes. , 2009, Journal of proteome research.

[45]  L. Frishman,et al.  Expression of vesicular glutamate transporter 1 in the mouse retina reveals temporal ordering in development of rod vs. cone and ON vs. OFF circuits , 2003, The Journal of comparative neurology.

[46]  J. Eichberg,et al.  Alterations in retinal Na+, K(+)-ATPase in diabetes: streptozotocin-induced and Zucker diabetic fatty rats. , 1993, Current eye research.

[47]  M. Stevens,et al.  Diabetes-Induced Changes in Retinal NAD-Redox Status , 2001, Pharmacology.

[48]  W. Freeman,et al.  The Retinal Proteome in Experimental Diabetic Retinopathy , 2009, Molecular & Cellular Proteomics.

[49]  M. Gillies,et al.  Proteome map of normal rat retina and comparison with the proteome of diabetic rat retina: New insight in the pathogenesis of diabetic retinopathy , 2007, Proteomics.

[50]  Stephen J. Aldington,et al.  Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69. , 2004, Archives of ophthalmology.

[51]  P. Chomczyński,et al.  A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. , 1993, BioTechniques.

[52]  H. D. Vanguilder,et al.  Chronic insulin treatment of diabetes does not fully normalize alterations in the retinal transcriptome , 2011, BMC Medical Genomics.